Viberzi® Pancreatitis Lawsuits

Eluxadoline, sold under the brand name Viberzi®, is a prescription medication used to treat patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D). Approved by the U.S. Food and Drug Administration (FDA) in 2015, the drug has recently been linked with an increased risk of developing serious—or even deadly—pancreatitis among patients who have had their gallbladder removed.

If you or someone you love took any amount of Viberzi without a gallbladder and suffered pancreatitis or symptoms of pancreatitis during or after May 2015, contact Ferrer, Poirot & Wansbrough now. Our drug injury attorneys want to help protect your rights to compensation for your IBS drug injury. Dial (800) 210-8503 or complete our free online form to get started anytime—24 hours a day, 7 days a week.

Viberzi® and IBS-D Patients Without Gallbladders

From May 2015 to February 2017, the FDA received 120 reports of serious pancreatitis or death. The deaths associated with pancreatitis after taking Viberzi involved patients without gallbladders.

Viberzi® Pancreatitis Risk

Patients have reported pancreatitis or pancreatitis symptoms after taking just one 75mg or 100mg dose of Viberzi. As a result of this potential complication, the FDA has recommended that Viberzi should not be used among patients who have:

  • no gallbladder,
  • a medical history involving a gallbladder blockage or sphincter of Oddi problem (SOD),
  • suffered from pancreatitis or pancreatic issues in the past,
  • a history of serious liver problems,
  • a history of chronic or severe constipation,
  • a history of alcohol abuse or drinks more than 3 alcoholic beverages a day,
  • or may have had an intestinal obstruction in the past.

Patients who suffer from IBS-D and fit any of the above risk factors may consider treating with over-the-counter medications or alternative prescription drugs.

Symptoms of Pancreatitis

Patients who take Viberzi should watch for symptoms of pancreatitis, such as:

  • Upper abdominal pain
  • Abdominal pain that radiates to the back
  • Abdominal pain that feels worse after eating
  • Fever
  • Rapid pulse
  • Nausea
  • Vomiting
  • Abdominal tenderness

If you or a family member experience any of these symptoms, contact a physician immediately to protect your health. Then call or contact us online to help protect your potential rights to compensation.

Get Help With Your IBS-D Pancreatitis Lawsuit

You’re not alone if you or your loved one developed pancreatitis or pancreatitis symptoms after taking Viberzi after May 2015. FDA data suggests patients without gallbladders faced an increased risk of severe illness or death after taking Viberzi, and our lawyers are here to listen to your story. Contact Ferrer, Poirot & Wansbrough now, and get a law firm with more than 30 years of experience on your side. Dial (800) 210-8503 or complete our free online form now.

Viberzi® is a registered trademark of Allergan, Plc, and is used here only for the purpose of identifying the product in question.

This law firm is not associated with, sponsored by, or affiliated with Allergan, Plc, or the U.S. Food and Drug Administration.